PNT

POINT Biopharma Global Inc. Common Stock

Delisted

PNT was delisted on the 26th of December, 2023.

67 hedge funds and large institutions have $316M invested in POINT Biopharma Global Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 24 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
67
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$14.9M
2 +$14.1M
3 +$6.32M
4
Millennium Management
Millennium Management
New York
+$4.49M
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$4.35M

Top Sellers

1 -$8.61M
2 -$4.33M
3 -$3.32M
4
Goldman Sachs
Goldman Sachs
New York
-$362K
5
LP
LMR Partners
United Kingdom
-$343K
Name Holding Trade Value Shares
Change
Change in
Stake
51
$120K
52
$117K
53
$117K
54
$108K
55
$101K
56
$100K
57
$98K
58
$98K
59
$94K
60
$92K
61
$60K
62
$54K
63
$29K
64
$21K
65
$9K
66
$2K
67
$1.63K
68
69
70
71
72
73